Authors:
HOGDALL CK
HOGDALL EVS
HORDING U
TOFTAGERLARSEN K
ARENDS J
NORGAARDPEDERSEN B
CLEMMENSEN I
Citation: Ck. Hogdall et al., USE OF TETRANECTIN, CA-125 AND CASA TO PREDICT RESIDUAL TUMOR AND SURVIVAL AT 2ND-LOOK AND 3RD-LOOK OPERATIONS FOR OVARIAN-CANCER, Acta oncologica, 35(1), 1996, pp. 63-69
Authors:
BLAAKAER J
HOGDALL CK
MICIC S
TOFTAGERLARSEN K
HORDING U
BENNETT P
BOCK J
Citation: J. Blaakaer et al., OVARIAN-CARCINOMA SERUM MARKERS AND OVARIAN-STEROID ACTIVITY - IS THERE A LINK IN OVARIAN-CANCER - A CORRELATION OF INHIBIN, TETRANECTIN AND CA-125 TO OVARIAN ACTIVITY AND THE GONADOTROPIN-LEVELS, European journal of obstetrics, gynecology, and reproductive biology, 59(1), 1995, pp. 53-56
Authors:
HOGDALL CK
HORDING U
NORGAARDPEDERSEN B
TOFTAGERLARSEN K
CLEMMENSEN I
Citation: Ck. Hogdall et al., SERUM TETRANECTIN AND CA-125 USED TO MONITOR THE COURSE OF TREATMENT IN OVARIAN-CANCER PATIENTS, European journal of obstetrics, gynecology, and reproductive biology, 57(3), 1994, pp. 175-178
Authors:
BLAAKAER J
MICIC S
MORRIS ID
HORDING U
BENNETT P
TOFTAGERLARSEN K
DJURSING H
BOCK JE
Citation: J. Blaakaer et al., IMMUNOREACTIVE INHIBIN-PRODUCTION IN POSTMENOPAUSAL WOMEN WITH MALIGNANT EPITHELIAL OVARIAN-TUMORS, European journal of obstetrics, gynecology, and reproductive biology, 52(2), 1993, pp. 105-110
Authors:
BLAAKAER J
BENNETT P
MICIC S
TOFTAGERLARSEN K
HORDING U
BOCK JE
LEBECH PE
Citation: J. Blaakaer et al., THE POSTOPERATIVE GONADOTROPIN LEVEL IN POSTMENOPAUSAL WOMEN WITH EPITHELIAL OVARIAN-CANCER, European journal of obstetrics, gynecology, and reproductive biology, 52(2), 1993, pp. 111-116
Authors:
BLAAKAER J
HOGDALL CK
HORDING U
BENNETT P
TOFTAGERLARSEN K
DAUGAARD S
BOCK J
Citation: J. Blaakaer et al., HORMONAL FACTORS AND PROGNOSIS IN EPITHELIAL OVARIAN-CANCER - A MULTIVARIATE-ANALYSIS, European journal of obstetrics, gynecology, and reproductive biology, 51(1), 1993, pp. 21-27
Authors:
HOGDALL CK
HOGDALL EVS
HORDING U
CLEMMENSEN I
NORGAARDPEDERSEN B
TOFTAGERLARSEN K
Citation: Ck. Hogdall et al., PREOPERATIVE PLASMA TETRANECTIN AS A PROGNOSTIC MARKER IN OVARIAN-CANCER PATIENTS, Scandinavian journal of clinical & laboratory investigation, 53(7), 1993, pp. 741-746